Plus contains sumatriptan (as the succinate), a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist, and naproxen sodium, a member of the arylacetic acid group of NSAIDs.
SUMATEC Plus is indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older.
Explore more products from our portfolio
